Komori
Ube (4208) · InitiativeAdvanced

Licensing of DMO and MEG Manufacturing Technology to Chinese Companies

First written in FY2017-Q1. 10 of 11 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2025-H1.

11entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017-Q1AdvancedFY2018-Q2 – FY2025-H12016: 120162017: 120172018: 220182019: 120192020: 020202021: 220212022: 020222023: 220232024: 22024
Same theme, other companies
Licensing of DMO, MEG and DMC manufacturing technologies to Chinese companiesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2025-H1AdvancedAnnual report

    「UBE Corporation (our company) 鄂尔多斯市双欣化学工业有限责任公司 6 September 2024 License agreement for DMC (dimethyl carbonate) manufacturing technology 20 years from the effective date of the agreement」

    A license agreement for DMC manufacturing technology was concluded with a Chinese company on 6 September 2024, with a term of 20 years from the effective date. The rollout of DMC technology in China continued and expanded.
  2. FY2024-Q3AdvancedAnnual report

    「UBE Corporation (our company) 荆门源晗电池材料有限公司 27 October 2023 License agreement for DMC (dimethyl carbonate) manufacturing technology 20 years from the effective date of the agreement」

    A new license agreement for DMC manufacturing technology was concluded with 荆门源晗电池材料有限公司 on 27 October 2023. The agreement term is 20 years from the effective date.
  3. FY2024-Q1AdvancedAnnual report

    「UBE Corporation (our company) 陕 煤集 团榆 林化学宇 高新材料有限責任公 司 28 April 2023 License agreement for HPDMC (high-purity dimethyl carbonate) and EMC (ethyl methyl carbonate) manufacturing technology 20 years from the effective date of the agreement」

    Under a new technical assistance agreement with a Chinese company, the scope of the licensed technology expanded beyond DMO, MEG and DMC to include HPDMC and EMC manufacturing technology. The agreement term is 20 years from the effective date.
  4. FY2023-Q3AdvancedAnnual report

    「UBE Corporation (our company) 临涣 焦化股份有限公司 21 November 2022 License agreement for DMC (dimethyl carbonate) manufacturing technology 20 years from the effective date of the agreement」

    A new license agreement for DMC manufacturing technology was concluded with 临涣焦化股份有限公司 on 21 November 2022, with a term of 20 years.
  5. FY2021AdvancedAnnual report

    「License agreement for DMC (dimethyl carbonate) manufacturing technology 15 January 2021 ハイケム株式会社」

    The rollout of DMC manufacturing technology and catalyst manufacturing technology licenses to Chinese companies and others continued and expanded.
  6. FY2021-Q3AdvancedAnnual report

    「UBE Corporation (our company) 利華益維远化学股份有限公司 14 December 2020 License agreement for DMC (dimethyl carbonate) manufacturing technology 20 years from the effective date of the agreement」

    A license agreement for DMC manufacturing technology was concluded with 利華益維远化学股份有限公司 on 14 December 2020, with a term of 20 years.
  7. FY2019AdvancedAnnual report

    「UBE Corporation (our company) 中国大唐集団公司 16 July 2018 陕煤集团榆林化学有限責任公司 18 August 2018 新疆致本精细化学有限公司 26 August 2018」

    In July and August 2018, license agreements for DMO and MEG manufacturing technology were added with 3 Chinese companies, expanding the rollout of the technology licenses.
  8. FY2019-Q1AdvancedAnnual report

    「UBE Corporation 山西松藍化工科技有限公司 License agreement for DMO (dimethyl oxalate) and MEG (monoethylene glycol) manufacturing technology 1 April 2018 (Until the patents and know-how expire)」

    A license agreement for DMO and MEG manufacturing technology was concluded with 山西松藍化工科技有限公司 on 1 April 2018.
  9. FY2018AdvancedAnnual report

    「License agreement for DMO (dimethyl oxalate) and MEG (monoethylene glycol) manufacturing technology 1 February 2018 山西沃能化工科技有限公司」

    An additional license for DMO and MEG manufacturing technology was granted to a Chinese company and others, continuing and expanding the rollout of the technology licenses.
  10. FY2018-Q2AdvancedAnnual report

    「License agreement for DMO (dimethyl oxalate) and MEG (monoethylene glycol) manufacturing technology 7 July 2017 License agreement for high-purity DMC (dimethyl carbonate) manufacturing technology 25 September 2017」

    An additional technology license was granted to a Chinese company, expanding the scope from DMO and MEG to high-purity DMC manufacturing technology.
  11. FY2017-Q1First statedAnnual report

    「陕西渭河彬州化工有限公司 License agreement for DMO (dimethyl oxalate) and MEG (monoethylene glycol) manufacturing technology 4 April 2016」

    A technical assistance agreement covering DMO and MEG manufacturing technology was concluded with a Chinese company. It remains effective until the patents and know-how expire.
Moved together

"Improvement in the Equity Ratio" moved the same way as this thread, in the same document, in 8 of its 11 moves.

854443★123456
  1. ★This thread
  2. 1Improvement in the Equity Ratio8×
  3. 2Expansion of capital investment, including growth and maintenance-related renewal5×
  4. 3Performance-linked dividends and returns to shareholders4×
  5. 4Risk of impairment of fixed assets due to deterioration in the business environment4×
  6. 5Integration of the cement and related businesses with Mitsubishi Materials4×
  7. 6Recovery in Chemicals Segment Performance3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Ube's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.